1. Home
  2. NATL vs RCKT Comparison

NATL vs RCKT Comparison

Compare NATL & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$43.78

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.54

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
RCKT
Founded
2023
1999
Country
United States
United States
Employees
N/A
202
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
534.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
NATL
RCKT
Price
$43.78
$3.54
Analyst Decision
Hold
Buy
Analyst Count
4
14
Target Price
$45.60
$29.73
AVG Volume (30 Days)
1.2M
4.2M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
73.98
N/A
EPS
2.14
N/A
Revenue
$4,354,000,000.00
N/A
Revenue This Year
$6.13
N/A
Revenue Next Year
$4.24
$51.17
P/E Ratio
$20.44
N/A
Revenue Growth
0.86
N/A
52 Week Low
$22.30
$2.19
52 Week High
$48.50
$8.26

Technical Indicators

Market Signals
Indicator
NATL
RCKT
Relative Strength Index (RSI) 53.05 38.79
Support Level $42.03 $2.99
Resistance Level $48.50 $4.08
Average True Range (ATR) 0.96 0.37
MACD -0.18 -0.16
Stochastic Oscillator 61.62 9.66

Price Performance

Historical Comparison
NATL
RCKT

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: